20
Views
4
CrossRef citations to date
0
Altmetric
Articles

Retrospective Comparison of Single-Agent Chemotherapy with Weekly 5-Fluorouracil or Weekly Irinotecan in Previously Treated Patients with Metastatic Colorectal Cancer

Pages 84-87 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shousong Cao, Arup Bhattacharya, Farukh A Durrani & Marwan Fakih. (2006) Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Expert Opinion on Pharmacotherapy 7:6, pages 687-703.
Read now
S. Man, K. Lavrenkov, A. Gluzman, D.B. Geffen & Y. Cohen. (2003) Chemotherapy with Irinothecan, 5-Fluorouracil and Folinic Acid in the First-Line Management of Advanced Colorectal Carcinoma: Retrospective Study. Journal of Chemotherapy 15:3, pages 304-305.
Read now

Articles from other publishers (1)

Nicolas Tsavaris, Christos Kosmas, Helias Skopelitis, Nicitas Papadoniou, Aristidis Polyzos, George Zografos, Efstathios Adoniou, John Gryniatsos, Evangelos Felekouras, Michalis Zacharakis, Francheska Sigala, Christos Bacoyiannis, George Papastratis & Efstathios Papalambros. (2007) Sequential Administration of 5-Fluorouracil (5FU)/Leucovorin (LV) Followed by Irinotecan (CPT-11) at Relapse versus CPT-11 Followed by 5-FU/LV in Advanced Colorectal Carcinoma. Chemotherapy 53:4, pages 282-291.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.